Hedge Fund and Insider Trading News: Philip Falcone, Ray Dalio, Continental Resources, Inc. (CLR), Sandy Spring Bancorp Inc. (SASR), Independent Bank Group Inc (IBTX), and More
Philip Falcone is ready for a bigger house.
Posts Tagged ‘Tesaro Inc. (TSRO)’
Here’s Why TESARO Inc (TSRO) Fell Sharply
Shares of TESARO Inc (NASDAQ:TSRO) are off almost 10% in afternoon trading on Thursday after the company announced the wholesale cost of 30 pills of ZEJULA 200mg at around $9833...
Clovis Oncology Inc (CLVS) is Trending After TESARO Inc (TSRO) Results
Niraparib, which goes by the brand name Zejula, is an once-daily oral PARP inhibitor.
AstraZeneca PLC (ADR) (AZN)’s Lynparza Trial Results Positive In Competitive Threat To Clovis Oncology Inc (CLVS) And TESARO Inc (TSRO)
Lynparza, an ovarian cancer treatment developed by AstraZeneca PLC (ADR) (NYSE:AZN) has demonstrated its ability to slow down disease progression.
Here’s What Just Happened With AstraZeneca PLC (ADR) (AZN), TESARO Inc (TSRO) And Clovis Oncology Inc (CLVS)
It’s been a big week for PARP inhibitors.
Clovis Oncology Inc (CLVS)’s Ovarian Cancer Drug Faces Stiff Competition From AstraZeneca PLC (ADR) (AZN), TESARO Inc (TSRO)
Trials of rival drugs from AstraZeneca PLC (ADR) (NYSE:AZN) and TESARO Inc (NASDAQ:TSRO) will determine the adoption of the PARP inhibitor, Rubraca from Clovis Oncology Inc (NASDAQ...
The Three Most Important Questions For TESARO Inc (TSRO) Shareholders Right Now
TESARO Inc (NASDAQ:TSRO) took a bit of a hit early Thursday morning, as the FDA announced it had issued a complete response letter (CRL) to the company relating to its latest ...
What We’re Watching In Biotech For January: Otonomy Inc (OTIC) And TESARO Inc (TSRO)
It’s going to be a busy month in the biotechnology sector.
Here’s Another Discount Entry Opportunity: TESARO Inc (TSRO)
TESARO Inc (NASDAQ:TSRO) just announced an equity offering, and the company has taken a considerable hit as a result.
Trending Stocks: TESARO, American Airlines, Delta, and More
The S&P 500 and NASDAQ index both opened in the green today after retail sales for October came in ahead of expectations.
Here’s Why Mylan, Diamondback Energy, TESARO and Two Other Stocks Are Surging Today
Climbing oil prices and polls suggesting Hillary Clinton’s success in the second presidential debate are favoring the market sentiment on Monday, as all three indices are trading...
Looking Ahead To The Potentially Game Changing TESARO Inc (TSRO) Data
TESARO Inc (NASDAQ:TSRO) just announced that the FDA has granted Fast Track designation to its lead ovarian, fallopian tube, or primary peritoneal cancer candidate, and that on...
Here’s Why Many Smart Money Investors Are Bullish on Clovis Oncology
Clovis Oncology Inc (NASDAQ:CLVS) is a biopharmaceutical company focused on developing and commercializing anti-cancer agents.
Here’s Why Traders Are Buzzing Around Lions Gate, Stellar Biotechnologies, and Three Other Stocks
Stocks are trading in the green on Thursday as markets continue to steadily recover from the Brexit-triggered wild swings.
Here’s Why These Five Stocks Are On the Move on Wednesday
Among the stocks showing more volatility than usual are TESARO Inc (NASDAQ:TSRO), Clovis Oncology Inc (NASDAQ:CLVS), PrivateBancorp Inc (NASDAQ:PVTB), Southwestern Energy Company...
Top Biotech Picks of Best-Performing Hedge Fund of 2015
Bloomberg recently came out with its list of best performing hedge funds of 2015 and the fund that managed to beat all its rivals and emerge at the top of the list was biotech...
Sientra Inc (SIEN), TESARO Inc (TSRO) and Clovis Oncology Inc (CLVS): Orbimed’s Top New Picks
Samuel Islay's Orbimed Advisors has revealed its equity portfolio as of end of 2014, in a recent filing with the Securities and Exchange Commission.
Biogen Idec Inc (BIIB) & TESARO Inc (TSRO): Top Biotech Stocks from Robyn Karnauskas Of Deutsche Bank
In the back drop of the biotech S&P ETF impacted by the S&P shedding market valuation by close to 7 % this week, Robyn Karnauskas who heads Deutsche Bank’s biotechnology vertical...
Insider Watch: 5 Stocks Scott D. Sandell Likes
Scott Sandell, a large shareholder and director with over 30 affiliations is the insider to watch for retail investors.
Hedge Funds Are Dumping Dendreon Corporation (DNDN)
To the average investor, there are tons of methods shareholders can use to monitor the equity markets.
Do Hedge Funds and Insiders Love Halozyme Therapeutics, Inc. (HALO)?
Now, according to many investors, hedge funds are seen as delayed, outdated financial tools of an era lost to time.
InterMune Inc (ITMN): Hedge Funds Aren’t Crazy About It, Insider Sentiment Unchanged
To many market players, hedge funds are perceived as delayed, old financial tools of a period lost to current times.
Idenix Pharmaceuticals Inc (IDIX), GenMark Diagnostics, Inc (GNMK): Horrendous Health-Care Stocks This Week
Shares of small biotech Idenix Pharmaceuticals Inc (NASDAQ:IDIX) took a 32% nosedive this week, following unwelcome news from the U.S. Food and Drug Administration.
Clovis Oncology Inc (CLVS), ACADIA Pharmaceuticals Inc. (ACAD): Three Humongous Health-Care Stocks This Week
Summer doesn't officially arrive for a few more weeks, but the first week of June packed some real heat.
Dendreon Corporation (DNDN): Are Hedge Funds Right About This Stock?
Dendreon Corporation (NASDAQ:DNDN) was in 13 hedge funds' portfolio at the end of March.
Clovis Oncology Inc (CLVS): Double Data, Double Stock Price
Plenty of data was presented at the American Society for Clinical Oncology meeting over the weekend, causing the first set of ASCO pops, but Clovis Oncology Inc (NASDAQ:CLVS) ...
Ambarella Inc (AMBA), Chuy’s Holdings Inc (CHUY): Are These Top Post-IPO Performers Still a Buy?
Investors are no stranger to large IPO pops, but in the last year we have seen incredible post-IPO runs, indicating that these companies were priced too cheap.
Aegerion Pharmaceuticals, Inc. (AEGR), TESARO Inc (TSRO), And Three Humongous Healthcare Stocks This Week
Up, up, and away. That's the motto for the market as a whole so far this year, but it's also especially applicable for a select group of stocks.
